LSUHSC Minority-Based Community Clinical Oncology Program

描述（由申请人提供）：路易斯安那州立大学新奥尔良健康科学中心（LSUHSC）MB-CCOP自1994年以来一直为该市及周边地区的非洲裔美国人和其他少数民族提供临床试验。2005年8月，卡特里娜飓风袭击了这座城市，这是自内战以来美国发生的最严重的自然和社会灾害。新奥尔良经历了美国所有城市中最大的大规模移民，以及最大的医生移民。特别是LSUHSC，失去了其主要招生地点慈善医院。它还失去了几乎所有的成年肿瘤学家和支持MB-CCOP的人员，该计划的病人分散。一个新的管理局-CCOP领导层实施了一项立即反应计划，并制定了一项长期重组战略。即时响应计划使我们能够招募一个团队，在2006年秋季之前跟踪90%的患者，恢复这些患者的医疗记录，并重新建立随访。长期计划旨在围绕与社区肿瘤学家的公私合作伙伴关系重建MB-CCOP基础设施。两年内，这些合作伙伴关系使我们能够显着增加入组人数，从而维持了我们为少数族裔和服务不足的患者提供最先进临床试验的承诺。这种从单一中心的MB-CCOP到基于社区的多中心项目的模式转变也使我们能够开始系统地分析私立和公立医疗机构中少数民族患者入组的不同障碍。我们更新申请的目标是解决这些障碍，并提高少数群体对MB-CCOP临床试验的参与。这将通过三个具体目标来实现：1）在公立医院和州癌症筛查诊所扩大MB-CCOP活动，2）通过私人肿瘤学合作伙伴关系促进MB-CCOP活动，3）制定有针对性的社区外展教育计划。

DESCRIPTION (provided by applicant): The Louisiana State University Health Sciences Center in New Orleans (LSUHSC) MB-CCOP has been providing access to clinical trials to African American and other minority populations in the city and surrounding regions since 1994. In August of 2005, the city was hit by Hurricane Katrina, the worst natural and social disaster to occur in the US since the Civil War. New Orleans experienced the largest mass migration of any US city, and the largest physician migration. LSUHSC, in particular, lost Charity Hospital, its principal enrollment site. It also lost virtually all adult oncologists and support MB-CCOP personnel, and the program's patients were dispersed. A new MB-CCOP leadership implemented an immediate response plan and established a long term reorganization strategy. The immediate response plan enabled us to recruit a team that tracked 90% of the patients by fall 2006, recovered the medical records of these patients, and reestablished follow-up. The long term plan aimed to rebuild the MB-CCOP infrastructure around a private-public partnership with community oncologists. Within two years, these partnerships allowed us to significantly increase our enrollment, maintaining our commitment of providing access to state-of-the-art clinical trials to minority and underserved patients. This paradigm shift from a single site, centrally based MB-CCOP to a community-based, multi-center program also allowed us to begin systematically analyzing the different barriers to minority patient enrollment in the private and public healthcare settings. The goal of our renewal application is to address these barriers and enhance the participation of minorities in MB-CCOP clinical trials. This will be accomplished through three Specific Aims directed at 1) expanding MB-CCOP activities at public hospitals and the state's cancer screening clinics, 2) promoting MB-CCOP activities through private oncology partnerships, and 3) developing targeted community outreach educational programs.